Southwest General Health Center

GHX Honors Top-Performing Healthcare Providers with 2023 Supply Chains of Distinction Award

Retrieved on: 
Tuesday, March 5, 2024
Hospital, Milford Regional Medical Center, Greater Baltimore Medical Center, Health, Brooklyn Hospital Center, Supply, Carteret Health Care, Southwest General Health Center, UW Health University Hospital, Newport News, Virginia, University, UC, Organization, Patient, Erie County Medical Center, Queen, Riverside Health System, Summit

LOUISVILLE, Colo., March 5, 2024 /PRNewswire/ -- Global Healthcare Exchange (GHX) today announced the inaugural class of its Supply Chains of Distinction Award for 2023, which recognizes top performing hospitals and health systems in North America.

Key Points: 
  • LOUISVILLE, Colo., March 5, 2024 /PRNewswire/ -- Global Healthcare Exchange (GHX) today announced the inaugural class of its Supply Chains of Distinction Award for 2023, which recognizes top performing hospitals and health systems in North America.
  • Industry-leading supply chains have evolved to become more automated, data-driven and resilient, giving rise to a set of best practice "perfect order" metrics that measure an organization's supply chain performance.
  • The Supply Chains of Distinction Award honors GHX Exchange-connected provider organizations that excelled in driving best-in-class supply chain operations.
  • The following organizations represent the class of 2023 Supply Chains of Distinction Award recipients.

VigiLanz Announces Winners of 2023 Vigi Awards

Retrieved on: 
Tuesday, August 29, 2023
Nursing, Sharp Memorial Hospital, Infection, Pharmacy, Hospital, MD, Patient, Physician, Southwest General Health Center, Antelope, Health, Drinking fountain, Safety, Pharmaceutical industry, Vaccine, Film industry

MINNEAPOLIS, Aug. 29, 2023 /PRNewswire/ -- VigiLanz, a clinical surveillance company, today announced the winners of the annual Vigi Awards, which honor innovative hospitals throughout the United States.

Key Points: 
  • MINNEAPOLIS, Aug. 29, 2023 /PRNewswire/ -- VigiLanz , a clinical surveillance company, today announced the winners of the annual Vigi Awards , which honor innovative hospitals throughout the United States.
  • The award winners are selected by VigiLanz based on nominations of individuals and teams submitted by VigiLanz customers.
  • "We are incredibly proud of this year's Vigi Award winners and it is an honor to have the opportunity to recognize their many accomplishments and advances in patient care," said David Goldsteen, MD, CEO of VigiLanz.
  • For more information on the Vigi Awards and the award winners, visit the VigiLanz website.

Sangamo Therapeutics Receives U.S. FDA Fast Track Designation for Isaralgagene Civaparvovec for the Treatment of Fabry Disease

Retrieved on: 
Monday, May 22, 2023
Science, Biotechnology, Research, Pharmaceutical, Health, FDA, Genetics, Clinical Trials, Priority review, Southwest General Health Center, Fabry disease, Therapy, STAAR, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Patient, Food, Accelerated approval (FDA), Pharmaceutical industry, Fabry, Sangamo Therapeutics

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to isaralgagene civaparvovec, or ST-920, a wholly owned gene therapy product candidate for the treatment of Fabry disease.

Key Points: 
  • Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to isaralgagene civaparvovec, or ST-920, a wholly owned gene therapy product candidate for the treatment of Fabry disease.
  • Companies granted this designation are given the opportunity for more frequent interactions with the FDA.
  • “We are thrilled with the FDA’s decision to grant Fast Track Designation for ST-920.
  • Fabry is a debilitating disease with life-long impact,” said Nathalie Dubois-Stringfellow, Ph.D, Sangamo’s Senior Vice President, Chief Development Officer.

Sangamo Therapeutics Announces Evidence of Clinical Benefit in Phase 1/2 STAAR Study in Fabry Disease

Retrieved on: 
Wednesday, February 22, 2023
Biotechnology, Health, Genetics, Pharmaceutical, Clinical Trials, Female, Therapy, Central nervous system, Annual report, Southwest General Health Center, Week, Sangamo Therapeutics, Form, Heart, STAAR, Cell, ERT, Marie Cassidy, Patient, Fabry disease, Trial of the century, Plasma, Kidney, Pathology, PTC, Urine, Good Samaritan Hospital Medical Center (West Islip, New York), Data, Pharmaceutical industry, MD, Eastern Time Zone, Fabry

These data, which present new biomarker data and results from the first kidney biopsies in this study, indicate evidence of clinical benefit for isaralgagene civaparvovec in Fabry disease.

Key Points: 
  • These data, which present new biomarker data and results from the first kidney biopsies in this study, indicate evidence of clinical benefit for isaralgagene civaparvovec in Fabry disease.
  • “Fabry is a debilitating disease with life-long impact,” said Dr. Robert Hopkin, MD, Cincinnati Children’s Hospital Medical Center, and investigator of the Phase 1/2 study.
  • Dosing of the remaining patients in the expansion phase of the Phase 1/2 STAAR study is ongoing, with a total of 20 sites active and recruiting.
  • Dosing of the first patient in the Phase 3 trial could begin as early as the first part of 2024.

Rootines announces launch of pediatric mental health monitoring

Retrieved on: 
Tuesday, July 19, 2022
Research, Ecosystem, Android, Social media, Patient, Microsoft, Hospital, Child, Sleep, OAK, Rootin' Tootin' Rhythm, CDC, Google Play, Environment, LLC, Software, Mental disorder, School, Caregiver, Statistics, Epilepsy, IOS, NICU, Element, HIPAA, Southwest General Health Center, Health, Community, COVID-19, Violence, Diet, Mental health, Parent, Medicine, Residential care, Autism

Experts agree that the pandemic has exacerbated these statistics, worsening pediatric mental health.

Key Points: 
  • Experts agree that the pandemic has exacerbated these statistics, worsening pediatric mental health.
  • To help address this growing concern, Rootines by ASD.ai LLC announces the addition of Mental Health as a condition monitoring category in their platform.
  • Marrying patient reported outcomes with remote patient monitoring, Rootines allows parents and caregivers to track various elements of health and well-being such as mood, sleep, diet and more.
  • Current conditions tracked on the Rootines platform include: General Health, Autism, Epilepsy and now Mental Health.

GHX Celebrates the Best 50 North American Healthcare Providers for Supply Chain Excellence

Retrieved on: 
Tuesday, March 8, 2022
Linda, Los Angeles County Department of Health Services, Organization, Hospital, Franciscan Missionaries of Our Lady University, Automation, Exchange, Mountain View, Newport News, Virginia, Loma Linda, California, Greater Baltimore Medical Center, Lehigh Valley Health Network, UC San Diego Health, Blanchard Valley Health System, UC, Health, Rush University Medical Center, CEO, Riverside Health System, Stanford University Medical Center, Southwest General Health Center, NYU Langone Health, Face, Nebraska Methodist Health System, Health insurance, Dentistry, Canal

LOUISVILLE, Colo., March 8, 2022 /PRNewswire/ -- Global Healthcare Exchange (GHX) today announced its annual list of the Best 50 supply chains, which recognizes the highest performing healthcare provider organizations in North America.

Key Points: 
  • LOUISVILLE, Colo., March 8, 2022 /PRNewswire/ -- Global Healthcare Exchange (GHX) today announced its annual list of the Best 50 supply chains, which recognizes the highest performing healthcare provider organizations in North America.
  • Honored for their work in improving operational performance while driving down costs through supply chain automation, the Best 50 honorees stand out among North America's premier hospitals for setting the standard for supply chain excellence.
  • "These leaders know that to achieve operational efficiency, cost-effectiveness and improve patient care, it's critical to fortify the supply chain through automation," said Bruce Johnson, president and CEO, GHX.
  • Organizations such as the Best 50 are leading healthcare toward a more value-driven future.

New Leaders, Chair Named to The Center for Health Affairs' Community Health Affairs Board of Directors

Retrieved on: 
Tuesday, January 25, 2022
Institute, Center, Knowledge, MPH, Hospital, Human, Organization, Efficiency, The Center, Master of Science, Time, DO, Health, CEO, Southwest General Health Center, Management, Medicine, Director

CLEVELAND, Ohio, Jan. 25, 2022 /PRNewswire/ -- The Center for Health Affairs is happy to announce the appointment of two new members to its Community Health Affairs Board of Directors .

Key Points: 
  • CLEVELAND, Ohio, Jan. 25, 2022 /PRNewswire/ -- The Center for Health Affairs is happy to announce the appointment of two new members to its Community Health Affairs Board of Directors .
  • , has been named chair, replacing Al Matyas, vice president of ambulatory operations and business development for Southwest General Health Center , who led the board since 2018.
  • Comprised of hospital, academic and community leaders in Northeast Ohio, the Community Health Affairs Board supports the organization in addressing healthcare needs and issues to improve health and wellness throughout the community.
  • The Community Health Affairs Board of Directors governs the 501(c)(6) Ohio nonprofit corporation and subsidiary of The Center for Health Affairs.

The Center for Health Affairs Names Leaders to its Affiliate Community Health Affairs Board of Directors

Retrieved on: 
Friday, October 22, 2021
Student Services, Efficiency, Director, Health Affairs, Hospital, Organization, Human, Center, Leadership, Time, Monte Ahuja College of Business, The Center, Cleveland State University, CEO, Health, Southwest General Health Center, Medicine, Management

Comprised of hospital, academic and community leaders in Northeast Ohio, the Community Health Affairs Board supports the organization in addressing healthcare needs and issues to improve health and wellness throughout the community.

Key Points: 
  • Comprised of hospital, academic and community leaders in Northeast Ohio, the Community Health Affairs Board supports the organization in addressing healthcare needs and issues to improve health and wellness throughout the community.
  • Anne E. Nelson, Assistant Dean of Student Services, Monte Ahuja College of Business, Cleveland State University
    "I am delighted to welcome this distinguished group of leaders to this board," said Al Matyas, Community Health Affairs Board Chair and Vice President of Ambulatory Operations & Business Development at Southwest General Health Center .
  • "Their breadth and depth of experience will bring valuable insights to our collaborative work aimed at serving our shared community."
  • The Community Health Affairs Board of Directors governs the 501(c)(6) Ohio nonprofit corporation and affiliate of The Center for Health Affairs and together with The Center's leadership aims to leverage the community's collective expertise and resources to implement collaborative solutions to healthcare challenges.

UnitedHealthcare Community Plan of Missouri Awards $500,000 to Address Health Equity

Retrieved on: 
Tuesday, October 19, 2021
Other Philanthropy, Insurance, Managed Care, General Health, Health, Hospitals, Professional Services, Philanthropy, Show, Sex, University of Central Missouri, School, Southwest General Health Center, Survivor, American Journal, Shoe, UNH, Social isolation, Twitter, Child, COVID-19, Health, Organization, NYSE, Housing, Transport, Health equity, Air conditioning, Community health center, Department, Medicaid, Contract, United States Department of Health and Human Services, Harmony House, Education, Domestic violence, Safety, Hospital, Infant, American Journal of Preventive Medicine, Substance abuse, Preventive healthcare, Partnership, Asthma, Kenosha County Healthy Homes Initiative, Physician, Food, Sexual assault, COPD, Medicare, Human services, Mortality, Medicine, Management

"We're honored to be supporting local organizations that offer essential resources to address social and economic factors that have a profound impact on people's health," said Jamie Bruce, chief executive officer of UnitedHealthcare Community Plan of Missouri.

Key Points: 
  • "We're honored to be supporting local organizations that offer essential resources to address social and economic factors that have a profound impact on people's health," said Jamie Bruce, chief executive officer of UnitedHealthcare Community Plan of Missouri.
  • Show-Me School-Based Health Alliance of Missouri $60,000 to provide school-based health services for children in high-risk and isolated communities in rural Southeast Missouri.
  • Community Health Center of Central Missouri $25,000 to purchase telehealth resources to provide health services such as doctor exams, screenings and behavioral health services in schools in Callaway and Cole counties.
  • We are very grateful to have received this grant from UnitedHealthcare Community Plan of Missouri to offer needed services and resources to individuals and families in our community, said Brooks Miller, chief executive officer of Jordan Valley Community Health Center.

aTyr Pharma Announces Positive Data from Phase 1b/2a Clinical Trial Demonstrating Consistent Dose Response for ATYR1923 in Pulmonary Sarcoidosis

Retrieved on: 
Monday, September 13, 2021
Oxygen, Idiopathic pulmonary fibrosis, ATyr Pharma, Pulmonology, Patient, Sarcoidosis, Granuloma, Prognosis, Interstitial lung disease, Department, Tumor necrosis factor, Research, Biology, Biomarker, Forward-looking statement, IP-10, Private Securities Litigation Reform Act, Fatigue, Southwest General Health Center, Annual report, ILD, Toxicity, IPF, COVID-19, Mixed connective tissue disease, GLOBE, Scar, IFN, Food, Neuropilin, ACE, Lung, SAA, Safety, Death, Interest, Goal, SEC, Effectiveness, Breathe Me, Cleveland Clinic, Quality of life, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, University, Steroid, LIFE, Inflammation, FVC, Risk, Fibrosis, RNA transfection, Disease, Cough, Population, FC, Vital capacity, Medical imaging, Dietary supplement, Pharmaceutical industry, Mineral wool

SAN DIEGO, Sept. 13, 2021 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a clinical stage biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, today announced positive results from its Phase 1b/2a double-blind, placebo-controlled clinical trial of its lead therapeutic candidate, ATYR1923, in 37 patients with pulmonary sarcoidosis, a major form of interstitial lung disease (ILD). ATYR1923 was safe and well-tolerated at all doses with no drug-related serious adverse events or signal of immunogenicity. Additionally, the study demonstrated consistent dose response for ATYR1923 on key efficacy endpoints and improvements compared to placebo, including measures of steroid reduction, lung function, sarcoidosis symptom measures and inflammatory biomarkers.

Key Points: 
  • Additionally, the study demonstrated consistent dose response for ATYR1923 on key efficacy endpoints and improvements compared to placebo, including measures of steroid reduction, lung function, sarcoidosis symptom measures and inflammatory biomarkers.
  • The dose response and consistent response seen across multiple efficacy measures, without added toxicity, in this patient population with advanced disease is notable.
  • The dose response and consistent results across almost every endpoint are remarkable findings, and as good as could be expected in this small study.
  • aTyr Pharma will host a conference call and webcast to discuss the results today, September 13th at 8:30am ET/5:30am PT.